¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"PRE"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • F42.0
    Predominantly obsessional thoughts or ruminations
    °­¹ÚÀû »ç°í ¶Ç´Â µÇ»õ±è
  • Y51.4
    Predominantly ¥á-adrenoreceptor agonists, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ¿ì¼¼¼º ¾ËÆÄ-¾Æµå·¹³ª¸° ¼ö¿ëü ÃËÁøÁ¦
  • T44.4
    Predominantly ¥á-adrenoreceptor agonists, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁÖ·Î ¾ËÆÄ¾Æµå·¹³¯¸° ¼ö¿ëü È¿´ÉÁ¦
  • Y51.5
    Predominantly ¥â-adrenoreceptor agonists, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ¿ì¼¼¼º º£Å¸-¾Æµå·¹³ª¸° ¼ö¿ëü ÃËÁøÁ¦
  • T44.5
    Predominantly ¥â-adrenoreceptor agonists, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁÖ·Î º£Å¸¾Æµå·¹³¯¸° ¼ö¿ëü È¿´ÉÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á